|
NEW YORK, NY – April 20, 2022 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY), a company that purports to be the world’s largest manufacturer of professional dental products and technologies.
On April 19, 2022, the Company issued a press release announcing the termination of Chief Executive Officer, Don Casey, effective immediately, and that Casey will also cease to serve as a member of the Company’s Board.
Following this news, shares of Dentsply Sirona dropped sharply by $6.52 per share, over 13%, to close at $42.20 per share on April 19, 2022.
If you purchased or otherwise acquired shares in Dentsply Sirona securities and would like to discuss our investigation, please contact us by emailing
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or by calling (646) 315-9003.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Kaplan Fox & Kilsheimer LLP, with offices in New York, San Francisco, Los Angeles, Chicago and New Jersey, has many years of experience in prosecuting investor class actions. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. If you have any questions about this investigation, your rights, or your interests, please contact:
Donald R. Hall
KAPLAN FOX & KILSHEIMER LLP
850 Third Avenue, 14th Floor
New York, New York 10022
(646) 315-9003
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax: (415) 772-4707
E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
